2019
DOI: 10.3389/fphar.2019.00995
|View full text |Cite
|
Sign up to set email alerts
|

The Many Faces of Mitochondrial Dysfunction in Depression: From Pathology to Treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
48
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
10

Relationship

3
7

Authors

Journals

citations
Cited by 42 publications
(55 citation statements)
references
References 44 publications
0
48
0
Order By: Relevance
“…Compared to ad libitum-fed controls, mice and rats on an IF diet exhibit less neuronal dysfunction, degeneration and fewer clinical symptoms in models of AD, PD and Huntington’s disease (HD) [ 16 ]. In a different in vivo study carried out by Chaix et al [ 61 ], there were 17 serum metabolites that were higher in TRF than ad libitum feeding group, including anserine and carnosine, which have shown therapeutic potential against the oxidative stress observed in pathologies characterized by cognitive dysfunctions [ 62 , 63 ]. Differently from caloric restriction, IF could prevent cognitive decline in a triple transgenic AD mouse model by acting on mitochondrial dysfunction and oxidative imbalance without reductions in β-amyloid protein and phospho-tau levels [ 64 ].…”
Section: Discussionmentioning
confidence: 99%
“…Compared to ad libitum-fed controls, mice and rats on an IF diet exhibit less neuronal dysfunction, degeneration and fewer clinical symptoms in models of AD, PD and Huntington’s disease (HD) [ 16 ]. In a different in vivo study carried out by Chaix et al [ 61 ], there were 17 serum metabolites that were higher in TRF than ad libitum feeding group, including anserine and carnosine, which have shown therapeutic potential against the oxidative stress observed in pathologies characterized by cognitive dysfunctions [ 62 , 63 ]. Differently from caloric restriction, IF could prevent cognitive decline in a triple transgenic AD mouse model by acting on mitochondrial dysfunction and oxidative imbalance without reductions in β-amyloid protein and phospho-tau levels [ 64 ].…”
Section: Discussionmentioning
confidence: 99%
“…Research methods designed to capitalize on mitonuclear interactions and detect incompatibilities as outlined in this review can be applied to other psychiatric disorders, as mitochondrial dysfunction is well documented in schizophrenia ( Goncalves et al, 2015 ; Hjelm et al, 2015 ; Monpays et al, 2016 ; Ben-Shachar, 2017 ; Ni and Chung, 2020 ; Roberts, 2020 ), depression ( Bansal and Kuhad, 2016 ; Allen et al, 2018 ; Caruso et al, 2019 ; Forester et al, 2019 ), autism ( Rossignol and Frye, 2012 ; Goh et al, 2014 ; Varga et al, 2018 ; Bennuri et al, 2019 ; Citrigno et al, 2020 ; Frye, 2020 ; Gevezova et al, 2020 ), and anxiety ( Chakravarty et al, 2013 ; Khalifeh et al, 2016 ; Babenko et al, 2018 ). The studies outlined in this review suggest that mitochondrial dysfunction underlying BD and other psychiatric disorders with genetic overlap may be the consequence of mitonuclear incompatibility, and may be enhanced in admixed populations with mitonuclear genomes originating from different ancestral populations ( Chou and Leu, 2015 ).…”
Section: Discussionmentioning
confidence: 99%
“…Depression has also been associated with mitochondrial dysfunctions and an increase in the formation of reactive oxygen species (ROS) inducing redox to unbalance and reduction in the energy production (adenosine triphosphate-ATP) ( Caruso et al, 2019 ). Oxidative stress activates several transcription factors, such as nuclear factor kappa B (NF-kB) leading to the production of pro-inflammatory cytokines and other inflammatory molecules acting as potent inducers of inducible nitric oxide synthase (iNOS) ( Morris and Berk, 2015 ).…”
Section: Vitamin D and Depressive Symptomsmentioning
confidence: 99%